Skip to content
10-Q

Quarterly Report

Evolutionary Genomics, Inc.

0001553350-19-001065

← back to feed
Filed
Oct 17, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2019 · Sep 30, 2019 5.88M sh
Short Term Investments Q3 2019 · Sep 30, 2019 $35.84K
Short Term Investments Q3 2019 · Dec 31, 2018 $28.2K
Current Liabilities Q3 2019 · Sep 30, 2019 $19.52K
Total Liabilities Q3 2019 · Sep 30, 2019 $974.97K
Total Liabilities Q3 2019 · Dec 31, 2018 $955.45K
Current Assets Q3 2019 · Sep 30, 2019 $296.87K
Current Assets Q3 2019 · Dec 31, 2018 $223.42K
Total Assets Q3 2019 · Sep 30, 2019 $4.43M
Total Assets Q3 2019 · Dec 31, 2018 $4.39M
Operating Cash Flow Q3 2019 · Sep 30, 2018 −$601.77K
Cash And Equivalents Q3 2019 · Sep 30, 2018 $278.47K
Cash And Equivalents Q3 2019 · Dec 31, 2017 $880.24K
Stockholders Equity Q3 2019 · Sep 30, 2018 $564.15K
Stockholders Equity Q3 2019 · Jun 30, 2018 −$804.81K
Stockholders Equity Q3 2019 · Mar 31, 2018 $1.14M
Stockholders Equity restated Q3 2019 · Dec 31, 2017 $1.4M
Sga Expense Q3 2019 · Sep 30, 2018 $44.17K
Sga Expense Q3 2019 · Sep 30, 2018 $174.66K
Rd Expense Q3 2019 · Sep 30, 2018 $114.69K
Rd Expense Q3 2019 · Sep 30, 2018 $374.93K
Net Income Q3 2019 · Sep 30, 2018 −$265.3K
Net Income Q3 2019 · Jun 30, 2018 −$358.04K
Net Income Q3 2019 · Mar 31, 2018 −$290.07K
Operating Income Q3 2019 · Sep 30, 2018 −$144.64K
Operating Income Q3 2019 · Sep 30, 2018 −$659.65K
Revenue Q3 2019 · Sep 30, 2018 $76.38K
Revenue Q3 2019 · Sep 30, 2018 $76.38K